Cargando…
Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that currently has no cure, but treatments are available to improve PD symptoms and maintain quality of life. In 2020, about 10 million people worldwide were living with PD. In 1970, the United States Food and Drug Administration a...
Autores principales: | Prasad, E. Maruthi, Hung, Shih-Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398928/ https://www.ncbi.nlm.nih.gov/pubmed/34451813 http://dx.doi.org/10.3390/ph14080717 |
Ejemplares similares
-
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
por: Prasad, E. Maruthi, et al.
Publicado: (2020) -
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
por: McFarthing, Kevin, et al.
Publicado: (2021) -
Arterial hypertension – Clinical trials update 2021
por: Al Ghorani, Hussam, et al.
Publicado: (2022) -
Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
por: Gouda, Noha A., et al.
Publicado: (2022) -
Gene Therapy for Parkinson’s Disease, An Update
por: Axelsen, Tobias M., et al.
Publicado: (2018)